Supplementary Material for: Growth Kinetics in Von Hippel-Lindau-Associated Renal Cell Carcinoma Jilg C.A. Neumann H.P. Gläsker S. Schäfer O. Ardelt P.U. Schwardt M. Schultze-Seemann W. 10.6084/m9.figshare.5122960.v1 https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Growth_Kinetics_in_Von_Hippel-Lindau-Associated_Renal_Cell_Carcinoma/5122960 <i>Objective:</i> To evaluate the growth kinetics of renal cell carcinoma (RCC) in von Hippel-Lindau (VHL) disease in a large trial by CT/MRI scan. VHL disease is a multisystemic disorder predisposing to renal cysts and cancer. There is a general assumption that VHL-associated RCC presents slower growth rates than sporadic RCC. <i>Patients and Methods:</i> We describe growth kinetics of 96 renal tumours in 64 VHL patients with analysed germline mutation (54/64 treated, 10/64 active surveillance) over a mean follow-up of 54.9 months. We calculated tumour volume, growth rate, multiplication of tumour volume per year and overall, as well as tumour volume doubling time. <i>Results:</i> The mean growth rate of 96 tumours was 4.4 mm/year (SD 3.2, median 4.1 mm/year), mean volume doubling time was 25.7 months (SD 20.2, median 22.2 months). We saw a median 1.4-fold increase in tumour volume per year. At treatment time point, VHL kidneys comprised 39% tumour and 15.7% cyst volume fraction. We saw no correlation between tumour size and growth parameters. <i>Conclusion:</i> VHL-associated RCC show large variances in tumour growth behaviour. Compared to the literature, in our study the growth rates (mm/year) of RCC in VHL disease did not differ from those of sporadic RCC. Fast tumour growth increases the risk for metastases. 2011-12-09 00:00:00 Von Hippel-Lindau disease Kidney cancer Renal cell carcinoma Growth kinetics